Titre : Cellulite orbitaire

Cellulite orbitaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit Disorder with Hyperactivity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellulite orbitaire : Questions médicales les plus fréquentes", "headline": "Cellulite orbitaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellulite orbitaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-16", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellulite orbitaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies du tissu conjonctif", "url": "https://questionsmedicales.fr/mesh/D003240", "about": { "@type": "MedicalCondition", "name": "Maladies du tissu conjonctif", "code": { "@type": "MedicalCode", "code": "D003240", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.300" } } }, "about": { "@type": "MedicalCondition", "name": "Cellulite orbitaire", "alternateName": "Orbital Cellulitis", "code": { "@type": "MedicalCode", "code": "D054517", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dinesh Selva", "url": "https://questionsmedicales.fr/author/Dinesh%20Selva", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology & Visual Sciences, University of Adelaide, North Terrace, 5000, Adelaide, South Australia, Australia." } }, { "@type": "Person", "name": "Terence Ang", "url": "https://questionsmedicales.fr/author/Terence%20Ang", "affiliation": { "@type": "Organization", "name": "Discipline of Ophthalmology & Visual Sciences, University of Adelaide, Adelaide, South Australia, Australia." } }, { "@type": "Person", "name": "Sanjay Mahant", "url": "https://questionsmedicales.fr/author/Sanjay%20Mahant", "affiliation": { "@type": "Organization", "name": "Pediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada." } }, { "@type": "Person", "name": "Peter J Gill", "url": "https://questionsmedicales.fr/author/Peter%20J%20Gill", "affiliation": { "@type": "Organization", "name": "Pediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada." } }, { "@type": "Person", "name": "Jessica Y Tong", "url": "https://questionsmedicales.fr/author/Jessica%20Y%20Tong", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology & Visual Sciences, University of Adelaide, North Terrace, 5000, Adelaide, South Australia, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Attention Deficit Hyperactivity Disorder (ADHD) and the gut microbiome: An ecological perspective.", "datePublished": "2023-08-18", "url": "https://questionsmedicales.fr/article/37594987", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0273890" } }, { "@type": "ScholarlyArticle", "name": "Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.", "datePublished": "2023-07-10", "url": "https://questionsmedicales.fr/article/37430151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40263-023-01023-6" } }, { "@type": "ScholarlyArticle", "name": "Investigating young-adult social outcomes of attention deficit hyperactivity disorder.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36922989", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4088/jcp.22m14379" } }, { "@type": "ScholarlyArticle", "name": "Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36508935", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpsychires.2022.11.029" } }, { "@type": "ScholarlyArticle", "name": "Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using", "datePublished": "2022-11-07", "url": "https://questionsmedicales.fr/article/36317558", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00498254.2022.2141151" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D003240" }, { "@type": "ListItem", "position": 4, "name": "Cellulite orbitaire", "item": "https://questionsmedicales.fr/mesh/D054517" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellulite orbitaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellulite orbitaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellulite orbitaire", "description": "Comment diagnostique-t-on la cellulite orbitaire ?\nQuels tests sanguins sont utiles ?\nQuels signes cliniques indiquent une cellulite orbitaire ?\nL'examen ophtalmologique est-il nécessaire ?\nQuand faut-il envisager une intervention chirurgicale ?", "url": "https://questionsmedicales.fr/mesh/D054517?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellulite orbitaire", "description": "Quels sont les symptômes courants de la cellulite orbitaire ?\nLa fièvre est-elle un symptôme fréquent ?\nPeut-on avoir des maux de tête avec cette condition ?\nY a-t-il des signes d'atteinte visuelle ?\nLes symptômes peuvent-ils évoluer rapidement ?", "url": "https://questionsmedicales.fr/mesh/D054517?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellulite orbitaire", "description": "Comment prévenir la cellulite orbitaire ?\nLes vaccinations aident-elles à prévenir cette condition ?\nFaut-il éviter les blessures au visage ?\nLes soins dentaires réguliers sont-ils importants ?\nLes allergies peuvent-elles augmenter le risque ?", "url": "https://questionsmedicales.fr/mesh/D054517?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellulite orbitaire", "description": "Quel est le traitement de première ligne ?\nQuand faut-il envisager une hospitalisation ?\nDes corticostéroïdes sont-ils utilisés ?\nLa chirurgie est-elle toujours nécessaire ?\nCombien de temps dure le traitement ?", "url": "https://questionsmedicales.fr/mesh/D054517?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellulite orbitaire", "description": "Quelles sont les complications possibles ?\nLa cellulite orbitaire peut-elle entraîner une septicémie ?\nQuels sont les risques de perte de vision ?\nLes complications sont-elles fréquentes ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D054517?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellulite orbitaire", "description": "Quels sont les principaux facteurs de risque ?\nLes enfants sont-ils plus à risque ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes allergies peuvent-elles jouer un rôle ?\nLe diabète est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D054517?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la cellulite orbitaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des examens d'imagerie comme l'IRM." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent montrer une élévation des globules blancs et des marqueurs d'infection." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une cellulite orbitaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent douleur, œdème, rougeur et parfois fièvre." } }, { "@type": "Question", "name": "L'examen ophtalmologique est-il nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il permet d'évaluer la vision et l'état de l'œil." } }, { "@type": "Question", "name": "Quand faut-il envisager une intervention chirurgicale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie est envisagée si l'abcès est suspecté ou si l'état s'aggrave." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la cellulite orbitaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, gonflement, rougeur et parfois vision floue." } }, { "@type": "Question", "name": "La fièvre est-elle un symptôme fréquent ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre est souvent présente chez les patients atteints." } }, { "@type": "Question", "name": "Peut-on avoir des maux de tête avec cette condition ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maux de tête peuvent accompagner la cellulite orbitaire." } }, { "@type": "Question", "name": "Y a-t-il des signes d'atteinte visuelle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la vision double ou la perte de vision peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils évoluer rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent s'aggraver rapidement, nécessitant une attention médicale urgente." } }, { "@type": "Question", "name": "Comment prévenir la cellulite orbitaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et traiter rapidement les infections des sinus." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir cette condition ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent réduire le risque d'infections qui mènent à la cellulite orbitaire." } }, { "@type": "Question", "name": "Faut-il éviter les blessures au visage ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les blessures au visage peut réduire le risque d'infection." } }, { "@type": "Question", "name": "Les soins dentaires réguliers sont-ils importants ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins dentaires réguliers peuvent prévenir les infections qui se propagent." } }, { "@type": "Question", "name": "Les allergies peuvent-elles augmenter le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les allergies non traitées peuvent contribuer à des infections des sinus." } }, { "@type": "Question", "name": "Quel est le traitement de première ligne ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement initial est généralement une antibiothérapie intraveineuse." } }, { "@type": "Question", "name": "Quand faut-il envisager une hospitalisation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire pour les cas graves ou compliqués." } }, { "@type": "Question", "name": "Des corticostéroïdes sont-ils utilisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des corticostéroïdes peuvent être administrés pour réduire l'inflammation." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, la chirurgie est réservée aux cas avec abcès ou complications." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut durer de plusieurs jours à plusieurs semaines selon la gravité." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'abcès, la perte de vision et la méningite." } }, { "@type": "Question", "name": "La cellulite orbitaire peut-elle entraîner une septicémie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une infection sévère peut se propager et causer une septicémie." } }, { "@type": "Question", "name": "Quels sont les risques de perte de vision ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La perte de vision peut survenir si la pression sur le nerf optique augmente." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent être graves, nécessitant une surveillance." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement précoce et approprié de l'infection est essentiel pour prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les infections des sinus, les traumatismes faciaux et les maladies systémiques augmentent le risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus susceptibles de développer une cellulite orbitaire." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées courent un risque accru d'infections." } }, { "@type": "Question", "name": "Les allergies peuvent-elles jouer un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les allergies non traitées peuvent favoriser les infections des sinus." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète mal contrôlé augmente le risque d'infections graves." } } ] } ] }

Sources (10000 au total)

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.

In our outpatient pediatric and adult psychiatry centers, we reserve psychostimulants for predominantly inattentive attention deficit hyperactivity disorder (ADHD) due to the potential for appetite an... 50 patients (35 children) received mean doses of atomoxetine 60 mg (25-100 mg once daily) followed by VER 300 mg (100-600 mg once daily) after a 5-day atomoxetine washout. Both atomoxetine and VER wer... From the baseline total ADHD-RS-5 mean score (40.3 ± 10.3), improvements were greater on VER (13.9 ± 10.2) than atomoxetine (33.1 ± 12.1; t = - 10.12, p < 0.00001) in inattention (t = - 8.57, p < 0.00... Pediatric and adult ADHD patients who have experienced less than optimal response to atomoxetine demonstrate rapid improvement in inattention and in hyperactivity/impulsivity with greater tolerability...

Investigating young-adult social outcomes of attention deficit hyperactivity disorder.

Attention Deficit Hyperactivity Disorder (ADHD) is associated with a range of adverse outcomes in adult life. However it is unclear whether the risk pathways to adverse adult outcomes are established ... We examined associations between broadly defined child-limited (remitted) and persistent ADHD (assessed using the ADHD subscale of the Strengths and Difficulties Questionnaire) with social outcomes (l... Up to 20% of young-people with less favourable social outcomes at age 25 had persistent ADHD. Persistent ADHD was associated with an increased likelihood of being not in education, employment or train... Our findings highlight the importance of continued monitoring and management of ADHD symptoms and related social as well as clinical outcomes across development into adulthood. Future research is need...

Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review.

Treatments for Adult ADHD include stimulants, two non-stimulant medications, as well as cognitive-behavioral therapy (CBT). These pharmacological agents are often associated with side effects, contrib... We systematically searched MEDLINE, EMBASE, EMCARE, PsycINFO, Web of Science, Cochrane Library, and Clinicaltrials.gov. The searches included all publications in English up to June 27, 2022. We includ... Our scoping review included a total of 39 studies. Only one study employed a randomized and placebo-controlled design to directly measure the effect of cannabis on ADHD, and no significant effect was ... Given the current evidence, cannabis is not recommended for people with ADHD. Limitations of the literature include the absence of objective measurements for cannabis exposure and ADHD symptoms, heter...

Cerebro-cerebellar Dysconnectivity in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.

Abnormal cerebellar development has been implicated in attention-deficit/hyperactivity disorder (ADHD), although cerebro-cerebellar functional connectivity (FC) has yet to be examined in ADHD. Our obj... We analyzed a dataset of 106 individuals with ADHD (68 children, 38 adolescents) and 62 healthy comparison individuals (34 children, 28 adolescents) from the publicly available ADHD-200 dataset. We id... Compared to comparisons, ADHD showed higher cerebro-cerebellar FC in the superior temporal gyrus within the somatomotor network. Interactions of diagnosis and age were identified in the supplementary ... Increased cerebro-cerebellar FC in the superior temporal gyrus within the somatomotor network could underlie impairments in cognitive control and somatic motor function in ADHD. In addition, increasin...

The friendships of children and youth with attention-deficit hyperactivity disorder: A systematic review.

Children with attention-deficit hyperactivity disorder (ADHD) experience substantial difficulty maintaining meaningful friendships, which has implications for social functioning and mental health. No ... To systematically review and methodologically appraise the quality of existing studies reporting on friendships of children with ADHD. To compare their friendships to typically-developing children, an... Six databases were searched. The methodological quality of studies was assessed using the QualSyst appraisal tool and the Appraisal tool for Cross-Sectional Studies. Aspects of friendships measured we... Twenty-three cross-sectional studies and one longitudinal follow-up study were included. Studies included 1509 participants with ADHD, with 1197 typically-developing participants used as a companion i... Limited longitudinal studies, small sample sizes and variability in measurement restrict the interpretations of friendship over time and the causal impact of friendship on social and emotional outcome...

A model of care for attention deficit and hyperactivity disorder among adults in the community.

To describe the process of collaborative, contextualised development and implementation of a model of care for adults with symptoms suggestive of attention deficit and hyperactivity disorder in an Abo... The current article describes an attempt to reduce unmet mental health needs through a systemic approach within a well-established Indigenous community-controlled organisation....

Attention-deficit/hyperactivity disorder and ischemic stroke: A Mendelian randomization study.

Observational studies have found an association between attention-deficit/hyperactivity disorder (ADHD) and ischemic stroke.... The purpose of this study was to investigate whether genetic liability to ADHD has a causal effect on ischemic stroke and its subtypes.... In this two-sample Mendelian randomization (MR) study, genetic variants (nine single-nucleotide polymorphisms;... Genetically determined ADHD (per 1 SD) was significantly associated with a higher risk of any ischemic stroke (AIS) (odds ratio (OR) = 1.15, 95% confidence interval (CI) = 1.05-1.25,... Genetic liability to ADHD was significantly associated with an increased risk of AIS, especially LAS. The association between ADHD and LAS was independent of age of smoking initiation but mediated by ...